Industry News/Vaccine Development

Biomira Presents Cancer Therapeutic Vaccine Data

Published in Vaccine Weekly, February 27th, 1995

Biomira's Director of Immunology Mark Reddish presented interim data from ongoing Phase II clinical trials of Theratope therapeutic vaccine.

The presentation, entitled Active Specific Immunotherapy of Adenocarcinomas Using Cancer-Associated Antigens was made at the Second Annual New Advances in Vaccine Technologies & Applications conference in Bethesda, Maryland.

As noted in the presentation, more than 50 percent of the patients studied are still alive in both the breast and ovarian groups, thus median survival time, in these late stage patients, is not yet available. The current breast and ovarian survival data, although preliminary, when tracked...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-02-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry